James E. Boers

1.5k total citations
30 papers, 1.1k citations indexed

About

James E. Boers is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, James E. Boers has authored 30 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 15 papers in Pulmonary and Respiratory Medicine and 10 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in James E. Boers's work include HER2/EGFR in Cancer Research (11 papers), Lung Cancer Diagnosis and Treatment (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). James E. Boers is often cited by papers focused on HER2/EGFR in Cancer Research (11 papers), Lung Cancer Diagnosis and Treatment (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). James E. Boers collaborates with scholars based in Netherlands, Germany and United States. James E. Boers's co-authors include Erik Thunnissen, Anton W. Ambergen, Jos A. Stigt, Harry J.M. Groen, Jan Willem Arends, J Koudstaal, G P ten Velde, Ad H. Oostdijk, Jelle Wesseling and Marc J. van de Vijver and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

James E. Boers

29 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James E. Boers Netherlands 17 592 338 264 249 128 30 1.1k
Mary Falzon United Kingdom 21 679 1.1× 292 0.9× 275 1.0× 371 1.5× 99 0.8× 45 1.4k
Atsushi Motegi Japan 20 495 0.8× 272 0.8× 237 0.9× 332 1.3× 92 0.7× 75 1.1k
Hiroaki Yasumoto Japan 21 367 0.6× 265 0.8× 460 1.7× 285 1.1× 112 0.9× 63 1.2k
Tomoyuki Nakagiri Japan 20 618 1.0× 332 1.0× 181 0.7× 386 1.6× 50 0.4× 64 1.3k
Jürgen Breul Germany 15 614 1.0× 263 0.8× 198 0.8× 147 0.6× 156 1.2× 44 976
Takashi Nishisaka Japan 18 586 1.0× 246 0.7× 239 0.9× 473 1.9× 51 0.4× 80 1.4k
Seiji Yano Japan 20 457 0.8× 625 1.8× 364 1.4× 293 1.2× 70 0.5× 117 1.3k
Yan Fu China 19 279 0.5× 499 1.5× 233 0.9× 218 0.9× 90 0.7× 50 994
Ryo Tanaka Japan 14 308 0.5× 411 1.2× 210 0.8× 223 0.9× 105 0.8× 51 956
Xiaoshun Shi China 17 610 1.0× 418 1.2× 353 1.3× 212 0.9× 148 1.2× 46 1.2k

Countries citing papers authored by James E. Boers

Since Specialization
Citations

This map shows the geographic impact of James E. Boers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James E. Boers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James E. Boers more than expected).

Fields of papers citing papers by James E. Boers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James E. Boers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James E. Boers. The network helps show where James E. Boers may publish in the future.

Co-authorship network of co-authors of James E. Boers

This figure shows the co-authorship network connecting the top 25 collaborators of James E. Boers. A scholar is included among the top collaborators of James E. Boers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James E. Boers. James E. Boers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rooijen, Johan M. van, Si-Qi Qiu, Hetty Timmer‐Bosscha, et al.. (2018). Androgen receptor expression inversely correlates with immune cell infiltration in human epidermal growth factor receptor 2–positive breast cancer. European Journal of Cancer. 103. 52–60. 20 indexed citations
2.
3.
Dekker, Tim, Gerrit K. Hooijer, Sybren L. Meijer, et al.. (2015). Quality assessment of estrogen receptor and progesterone receptor testing in breast cancer using a tissue microarray-based approach. Breast Cancer Research and Treatment. 152(2). 247–252. 16 indexed citations
4.
Rooijen, Johan M. van, Linda de Munck, Jacques C. de Graaf, et al.. (2015). Use of trastuzumab for HER2-positive metastatic breast cancer in daily practice. Anti-Cancer Drugs. 27(2). 127–132. 6 indexed citations
5.
Stigt, Jos A., James E. Boers, & Martijn F. Boomsma. (2015). Ultrasound-Guided Tissue Core Biopsies in Supraclavicular Lymph Nodes in Patients with Suspected Thoracic Malignancies. Respiration. 90(5). 412–415. 7 indexed citations
6.
Meulendijks, Didier, Laurens V. Beerepoot, Henk Boot, et al.. (2015). Trastuzumab and bevacizumab combined with docetaxel, oxaliplatin and capecitabine as first-line treatment of advanced HER2-positive gastric cancer: a multicenter phase II study. Investigational New Drugs. 34(1). 119–128. 28 indexed citations
7.
Rooijen, Johan M. van, et al.. (2014). Limited human epidermal growth factor receptor 2 discordance in metastatic breast cancer patients treated with trastuzumab, a population based study. European Journal of Cancer. 50(5). 885–891. 6 indexed citations
8.
Groep, Petra van der, Marc J. van de Vijver, James E. Boers, et al.. (2013). Discordance in ERα, PR and HER2 receptor status across different distant breast cancer metastases within the same patient. Annals of Oncology. 24(12). 3017–3023. 41 indexed citations
9.
Stigt, Jos A., James E. Boers, & Harry J.M. Groen. (2012). Analysis of ?dry? mesothelioma with ultrasound guided biopsies. Lung Cancer. 78(3). 229–233. 27 indexed citations
10.
Boers, James E., et al.. (2011). High Concordance of 5 HER2 In Situ Hybridization Methods with Abbott FISH.. Laboratory Investigation. 71. 1 indexed citations
11.
12.
Seicean, Radu, Doiniţa Crişan, James E. Boers, et al.. (2011). The Prognostic Role of Apoptosis Mediators in Rectal Adenocarcinoma. Hepatogastroenterology. 58(110-111). 1490–4. 5 indexed citations
13.
Stigt, Jos A., James E. Boers, Ad H. Oostdijk, Jan Willem van den Berg, & Harry J.M. Groen. (2011). Mediastinal Incidentalomas. Journal of Thoracic Oncology. 6(8). 1345–1349. 22 indexed citations
14.
Stigt, Jos A., Ad H. Oostdijk, James E. Boers, Jan Willem van den Berg, & Harry J.M. Groen. (2011). Percutaneous Ultrasound-Guided Biopsies in the Evaluation of Thoracic Tumours after PET-CT: A Prospective Diagnostic Study. Respiration. 83(1). 45–52. 12 indexed citations
15.
Stigt, Jos A., Ad H. Oostdijk, Paul R. Timmer, et al.. (2009). Comparison of EUS-guided fine needle aspiration and integrated PET-CT in restaging after treatment for locally advanced non-small cell lung cancer. Lung Cancer. 66(2). 198–204. 43 indexed citations
16.
17.
Boers, James E., Anton W. Ambergen, & Erik Thunnissen. (1999). Number and Proliferation of Clara Cells in Normal Human Airway Epithelium. American Journal of Respiratory and Critical Care Medicine. 159(5). 1585–1591. 225 indexed citations
18.
Boers, James E., Anton W. Ambergen, & Erik Thunnissen. (1998). Number and Proliferation of Basal and Parabasal Cells in Normal Human Airway Epithelium. American Journal of Respiratory and Critical Care Medicine. 157(6). 2000–2006. 194 indexed citations
19.
Boers, James E., G P ten Velde, & Erik Thunnissen. (1996). P53 in Squamous Metaplasia: A Marker for Risk of Respiratory Tract Carcinoma. American Journal of Respiratory and Critical Care Medicine. 153(1). 411–416. 46 indexed citations
20.
Boers, James E., et al.. (1996). Number and Proliferation of Neuroendocrine Cells in Normal Human Airway Epithelium. American Journal of Respiratory and Critical Care Medicine. 154(3). 758–763. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mary Falzon Breakdown of academic impact, for papers by Atsushi Motegi Breakdown of academic impact, for papers by Hiroaki Yasumoto Breakdown of academic impact, for papers by Tomoyuki Nakagiri Breakdown of academic impact, for papers by Jürgen Breul Breakdown of academic impact, for papers by Takashi Nishisaka Breakdown of academic impact, for papers by Seiji Yano Breakdown of academic impact, for papers by Yan Fu Breakdown of academic impact, for papers by Ryo Tanaka Breakdown of academic impact, for papers by Xiaoshun Shi
Rankless by CCL
2026